Understanding the Pharmacovigilance Failures: How Post-Market Surveillance of Oxbryta May Have Missed Emerging Risks
Oxbryta Lawsuit: How a Promising Sickle Cell Drug Sparked Legal Action Oxbryta was approved to treat sickle cell disease and reduce life-threatening symptoms like vaso occlusive crises. But soon after its release, patients began reporting